Table 3.

Clinical features of hepatitis-negative patients with MPGN and lymphoproliferative disorders or MM

Patient	Age (years)	Gender	BP (mmHg)	SCr (mg/dl)	Proteinuria (g/24 h)	CrCl (ml/min)	SPEP	SIFE	UPEP	UIFE	Cryo	κ FLC, λ FLC, κ/λ Ratio	Clinical Diagnosis
17	68	F	174/79	1.5	4.5	44	Hypo	IgG and IgM λ	Negative	IgG λ	Negative	1.86, 1.81, 1.03	LGBCL
18	43	F	155/93	2.2	4.8	36	Abnormal fraction	IgG λ	M spike	λ	ND	0.670, 63.400, 0.010	MM
19	70	M	–	5.6	5.3	6	Negative	IgM κ and IgM λ	Negative	Negative	Negative	ND	CLL
20	82	M	156/88	1.9	10.2	44	Abnormal fraction	IgM κ and IgG λ	ND	IgG λ	Negative	4.53, 2.56, 1.77	LGBCL
21	75	M	150/60	2.4	4.084	25	Abnormal fraction	IgM and IgG κ	ND	IgG κ	Type I (IgG κ)	5.21, 1.73, 3.01	CLL
22	33	F	112/80	1.7	0.311	35	Negative	Negative	Negative	IgG κ	ND	45.30, 2.64, 17.20	MM
23	63	M	111/67	1.3	5.216	32	M spike	Monoclonal IgG κ	M spike	IgG κ	ND	12.80, 17.40, 0.74	MM
24	71	M	130/70	1.5	1.815	40	M spike	Monoclonal IgM κ	Negative	κ	Negative	16.70, 0.89, 18.80	LPL
25	54	M	130/78	1.5	8.2	52	M spike	Monoclonal IgG κ	M spike	IgG κ	Negative	157.00, 1.61, 97.50	MM
26	77	F	155/81	1.3	8.3	42	Hypo	Monoclonal IgM κ	Negative	IgM κ	Type II	ND	LGBCL
27	60	M	145/87	2.3	2.9	31	M spike	Monoclonal IgG λ	Negative	IgG λ	Negative	3.17, 5.55, 0.57	MM
28	61	F	121/59	2.2	3.1	24	Hypo	Monoclonal IgG κ	Negative	Negative	Negative	1.46, 1.10, 1.33	MM

CrCl, creatinine clearance; Cryo, cryoglobulins; FLC, free light chains (reference range κ FLC 0.33 to 1.94 mg/dl, λ FLC 0.57 to 2.63 mg/dl, κ/λ ratio 0.26 to 1.65); Hypo, hypogammaglobulinemia; ND, not done, SCr, serum creatinine.